SIXNOCID

This brand name is authorized in Nigeria.

Active ingredients

The drug SIXNOCID contains one active pharmaceutical ingredient (API):

1	Clobetasol propionate UNII 779619577M - CLOBETASOL PROPIONATE
	Clobetasol propionate, like other topical corticosteroids, has anti-inflammatory, antipruritic, and vasoconstrictive properties. Corticosteroids are thought to act by the induction of phospholipase A2 inhibitory proteins, collectively called lipocortins. It is postulated that these proteins control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes by inhibiting the release of their common precursor arachidonic acid.
	Read more about Clobetasol propionate

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-100381	Cream	SIXNOCID CREAM CREAM 0.05%; 1% 30GM tube	SIXNOCID CREAM Clobetasol Propionate USP 0.05 % w/w & Clotrimazole BP 1.00 % w/w Clobetasol Propionate USP 0.05 % w/w Clotrimazole BP 1.00 % w/w Cream Base Q.S. List of excipients Cetamacrogal 1000 Cetostearyl Alcohol White Soft Paraffin Methyl Paraben Propyl Paraben Sodium Acid Phosphate Disodium Hydrogen Phosphate Propylene Glycol Light Liquid Paraffin Iso-Propyl Myristate Dimethicone 100 cps Purified Water Drugs Imported Products 30GM tube Prescription Only Medicine (POM) 22/02/2023 ONIFAM LABORATORIES LIMITED, IDIMU ROAD, ORELOPE EGBEDA, LAGOS. EGBEDA LAGOS 17763208 onifamconsultant@yahoo.com M/S COTEC HEALTHCARE PVT LTD , KHASRA NO.593/1, NH-74, ROORKEE DEHRADUN HIGHWAY KISHANPUR, ROORKEE, DIST-HARIDWAR, UTTARAKHAND, INDIA., India	26/04/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
D07AD01	Clobetasol	D Dermatologicals → D07 Corticosteroids, dermatological preparations → D07A Corticosteroids, plain → D07AD Corticosteroids, very potent (group IV)
Discover more medicines within D07AD01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-100381